Rheumatology Advisor Contributing Writer

The American College of Rheumatology and the Arthritis Foundation developed evidence-based guidelines for the management of hand, hip, and knee osteoarthritis.

Researchers studied the risk factors for relapse, including prednisolone clearance and glucocorticoid-induced transcript 1 promoter polymorphism (rs37972), in patients with giant cell arteritis.

Researchers addressed the association between cardiovascular risk and glucocorticoids in patients with systemic lupus erythematosus.

Researchers evaluated the safety and efficacy of a sublingual formulation of cyclobenzaprine in fibromyalgia.

Researchers compared the rate of opioid overdose-related hospitalizations among patients with systemic lupus erythematosus and rheumatoid arthritis vs the general population.

Researchers evaluated the efficacy and safety of guselkumab in patients with active psoriatic arthritis who were biologic-naive or treated with prior tumor necrosis factor inhibitors.

Treatment with broad-spectrum beta-lactam antibiotics, including sulfonamide and trimethoprim, may be associated with a diagnosis of rheumatoid arthritis (RA) or increased risk for RA flares, according to research.

Researchers evaluated the efficacy and safety of abatacept in pediatric patients with polyarticular-course juvenile idiopathic arthritis.

Researchers assessed the demographics associated with the admission of acute myocardial infarction and evaluated the differences between rheumatoid arthritis and gout and osteoarthritis.

The following article is a part of conference coverage from the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, being held in Atlanta, Georgia. The team at MPR will be reporting on the latest news and research conducted by leading experts in rheumatology. Check back for more from the 2019 ACR/ARP Annual…